Penarth mum ‘begged’ for MRI which revealed cervical cancer

A devastating diagnosis of stage 1B3 cervical cancer, requiring urgent and aggressive treatment, has left Jessica Mason, a 44-year-old mother from Penarth, feeling a profound loss of faith in the medical professionals who she believes failed to adequately investigate her persistent and worrying symptoms for years. Ms. Mason’s harrowing experience highlights what a recent Senedd health committee report has described as "critical failures" and "inaction" by the Welsh government in addressing gynaecological cancer care, leaving women like her feeling "let down." It was only after Ms. Mason "begged" for an MRI scan, following years of being "fobbed off" with various diagnoses and assurances that nothing serious was wrong, that the life-threatening condition was finally revealed.

"I knew there was something wrong," Ms. Mason stated emphatically, recounting the distressing period that began in 2019 when she started experiencing significant vaginal bleeding, pain, and swelling. These symptoms, which she diligently reported to her GP and hospital on multiple occasions, were met with a series of investigations that failed to identify the root cause. Ultrasounds were performed, yielding no conclusive results, and Ms. Mason was subsequently given diagnoses ranging from a simple cyst and endometriosis to a prolapse, for which she was advised to undertake pelvic floor exercises. This pattern of dismissal and misdiagnosis left her feeling increasingly confused and disbelieved. "It was so confusing because you trust in the doctors and you think if it was something serious they would have known," she explained, her voice tinged with lingering frustration.

Adding to the distress, a routine smear test conducted just six months prior to her eventual diagnosis also came back clear, further compounding the sense that her concerns were not being taken seriously. The turning point, however, arrived in May 2022, during an appointment at the University Hospital of Wales in Cardiff to discuss the results of yet another ultrasound. It was at this juncture that Ms. Mason, overwhelmed by the lack of progress and the persistent feeling that her symptoms were being overlooked, broke down in tears. "They said there was something on the lining of the womb but it all looked OK," she recalled, her voice heavy with emotion. "I begged them to do something more to check what could be causing my symptoms as I felt I wasn’t being believed."

It was only after this emotional plea that medical professionals finally offered an MRI scan, a procedure Ms. Mason described as being offered to provide her with "peace of mind." The results, received a couple of weeks later in June 2022, delivered a devastating blow. "Cancer didn’t cross my mind to be honest, I thought it would be something like an infection, I didn’t think it was going to be that serious," she admitted. The doctor informed her that she had stage 1B3 cervical cancer and that immediate treatment was imperative.

The subsequent treatment regimen, which commenced in August 2022, involved a gruelling five-week course of chemotherapy and radiotherapy. This aggressive treatment, while vital for combating the cancer, took a significant toll on Ms. Mason’s physical and emotional well-being. It not only impacted her 13-year-old son, who had to witness his mother’s struggle and endure the disruption to their family life, but also induced an early menopause, prematurely ending her hopes of having another child. "I couldn’t cook and couldn’t clean, I couldn’t even iron my son’s uniform or take him to school," she revealed, painting a stark picture of her debilitating fatigue and weakness.

Ms. Mason firmly believes that an earlier referral for an MRI scan could have potentially altered the course of her diagnosis and treatment. She pointed out the financial implications, stating, "The cost of the MRI is probably just as much as the amount spent on treatment, GP and doctor appointments." However, her ordeal was far from over. A further MRI scan in February 2023 revealed that the tumour had persisted, necessitating a hysterectomy in July 2023.

The prolonged and arduous journey has left Ms. Mason feeling deeply disillusioned. "I lost my faith in the doctors," she confessed, her voice laced with a profound sense of betrayal. "It’s horrible because obviously I’m not a medical expert and you’ve got to put your faith in them but I’m always questioning them." Once a full-time worker, Ms. Mason now finds herself able to manage only three days a week, a testament to the enduring impact of her illness and treatment. "It took over our lives. My body is wrecked from everything I’ve been through but mentally too, my friends, my family, my home life, everything just revolves around that."

The fight for Ms. Mason continues, as she still experiences occasional bleeding and faces the prospect of further biopsies, describing her situation as "never-ending." The constant fear of recurrence looms large. "I’ve always got this worry in the back of my head, what if they miss something again and this time I don’t survive it?" she expressed, her voice trembling. Adding to her distress, she has accused the health board of deliberately "dragging their heels" in providing her with her medical records, as she contemplates legal action. Her experience has led her to observe, with deep concern, that "A lot of women-specific issues are just not recognised [quickly] enough. They just dismiss it as ‘your time of the month’ or ‘women’s issues’."

In response to Ms. Mason’s experience, a spokesperson for Cardiff and Vale University Health Board stated, "We are sorry to hear about Jessica’s experience while in our care and acknowledge the challenges surrounding her cancer diagnosis. As it would be inappropriate to comment on an individual patient case, and due to ongoing legal proceedings, we are unable to comment further."

The issues raised by Ms. Mason’s case are echoed in a recent Senedd health committee report into gynaecological cancer care in Wales. The report starkly concluded that women are "still being let down by the Welsh government’s inaction." It highlighted a failure to implement numerous recommendations made in December 2023, which aimed to address "critical failures" in the system. Despite the Welsh government’s acceptance of most of these recommendations, the report noted a lack of specific ring-fenced funding for gynaecological cancer services and the absence of measurable NHS targets for improving outcomes. Furthermore, Wales has been found to be falling short of crucial waiting time targets, with only 41% of patients commencing treatment within the 62-day target in October 2025.

Cancer charity Tenovus expressed its deep concern, stating it was "deeply concerning to see in black and white just how little progress has been made." In its defence, the Welsh government stated its commitment to working with the NHS to enhance access to timely diagnosis and treatment for women with gynaecological cancer. They highlighted recent changes designed to support earlier referrals and investments in new equipment and treatments aimed at improving women’s outcomes. Acknowledging the current performance against the 62-day target as "simply not good enough," the government asserted that the Women’s Health Plan is actively driving "real change in women’s healthcare in Wales." However, for individuals like Jessica Mason, the impact of delayed diagnosis and the perceived systemic failures continues to cast a long and dark shadow.